김형석

김형석 discloses dealings in 리가켐바이오 to DART (FSS). Over a trading history stretching from 23 July 2021 to 1 July 2024, the count stands at 4 filings.

Purchases make up the whole of the open-market record (1 purchase). The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: 1 purchase and no sales on the market.

Most recently, on 1 July 2024, the filings show an open-market purchase in 리가켐바이오. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.